Serum fucosylated haptoglobin as a novel prognostic biomarker predicting high-Gleason prostate cancer

Pathological, Oncologic and Functional Outcomes of Radical Prostatectomy Following Active Surveillance

(2013) Raj Satkunasivam et al.   JOURNAL OF UROLOGY

Pathological Outcomes in Men with Low Risk and Very Low Risk Prostate Cancer: Implications on the Practice of Active Surveillance

(2013) Jeffrey J. Tosoian et al.   JOURNAL OF UROLOGY

Population Based Study of Predictors of Adverse Pathology among Candidates for Active Surveillance with Gleason 6 Prostate Cancer

(2013) Annelies Vellekoop et al.   JOURNAL OF UROLOGY

Reevaluation of a lectin antibody ELISA kit for measuring fucosylated haptoglobin in various conditions

(2012) Yoshihiro Kamada et al.   CLINICA CHIMICA ACTA

A Multi-Institutional Evaluation of Active Surveillance for Low Risk Prostate Cancer

(2012) Scott E. Eggener et al.   JOURNAL OF UROLOGY

Fucosyltransferase 8 as a functional regulator of nonsmall cell lung cancer

(2012) C.-Y. Chen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Fucosylated haptoglobin is a novel type of cancer biomarker linked to the prognosis after an operation in colorectal cancer

(2011) Yuri Takeda et al.   CANCER

Prostate Specific Antigen Density to Predict Prostate Cancer Upgrading in a Contemporary Radical Prostatectomy Series: A Single Center Experience

(2009) Ahmed Magheli et al.   JOURNAL OF UROLOGY